Cryo-EM of ATP-driven dynamics and itraconazole binding of the fungal drug efflux ABC pump Candida glabrata Cdr1
Pata, J.; Wiseman, B.; Zarkadas, E.; Baccouch, R.; Samrouth, N.; Desbois, C.; Moissonier, L.; Moreno, A.; Banerjee, A.; Aguerro, S.; Bettler, E.; Dujardin, M.; Magnard, S.; Terreux, R.; Schoehn, G.; Hogbom, M.; Boumendjel, A.; Lamping, E.; Cannon, R.; Prasad, R.; Chaptal, V.; Falson, P.
Show abstract
Azole resistance in Candida species is often caused by the overexpression of Cdr1. Despite its clinical relevance, the structural basis for its ATP-driven efflux pump function remains elusive. We present four high-resolution cryo-EM structures for Candida glabrata Cdr1 under active turnover conditions in the absence and presence of ATP-Mg{superscript 2}, itraconazole, and vanadate. Additional transient cryo-EM structures were unveiled by 3D variability analysis offering a detailed view of the step-by-step transitions triggered by ATP-hydrolysis. The motion cascade starts with a 4 [A] piston-like retraction of the C-helix from the {gamma}-phosphate/vanadate of the hydrolyzed ATP. This causes the nearby transmembrane helix-1 (TMH-1) to open the drug-binding site via lateral displacement and unwinding of the inner-leaflet region of TMH-2. A reverse squeeze-and-push motion of TMH-2 possibly drives substrate extrusion. High resolution structures also reveal how itraconazole adapts its shape to fit into the drug-binding site. Our findings provide a dynamic structural framework for Cdr1-mediated azole resistance and the conserved chemo-mechanical cycle of ABC proteins, including non-membranous members.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.